The control of tumour growth by restricting angiogenesis has attracted tremendous attention in recent years. The initial work using anti-angiogenic drugs alone was promising but did not translate into ...
Pulmonary vascular function is impaired with increased pulmonary blood flow (PBF). We hypothesized that a peroxisome proliferator–activated receptor-γ (PPAR-γ) agonist would mitigate this effect. An ...